Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 30, Issue 2, Pages 150-159
Publisher
Wiley
Online
2015-01-22
DOI
10.1002/mds.26099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managing impulse control behaviours in Parkinson's disease: practical guidelines
- (2014) Graeme JA Macphee et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1
- (2014) Björn Albrecht et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- (2014) P. J. Garcia-Ruiz et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study
- (2014) K. Papay et al. NEUROLOGY
- Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task
- (2013) Daniel Scott et al. BEHAVIOURAL BRAIN RESEARCH
- Catechol-O-Methyltransferase Genotype Modulates Opioid Release in Decision Circuitry
- (2013) Jennifer M. Mitchell et al. CTS-Clinical and Translational Science
- Dopamine Agonist Withdrawal Syndrome: Implications for Patient Care
- (2013) Melissa J. Nirenberg DRUGS & AGING
- Dopamine-agonists and impulsivity in Parkinson's disease: Impulsive choices vs. impulsive actions
- (2013) Francesca Antonelli et al. HUMAN BRAIN MAPPING
- Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease
- (2013) A. Eusebio et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
- (2013) V. Voon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
- (2013) Paolo Calabresi et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease
- (2013) María José Catalán et al. MOVEMENT DISORDERS
- Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
- (2013) Michael S. Okun et al. MOVEMENT DISORDERS
- Prospective cohort study of impulse control disorders in Parkinson's disease
- (2013) Jesse Bastiaens et al. MOVEMENT DISORDERS
- Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
- (2013) D. Okai et al. NEUROLOGY
- Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin?
- (2013) Chris Vriend et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease
- (2013) Barbara Connolly et al. Neurotherapeutics
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases
- (2013) Carmine Vitale et al. PARKINSONISM & RELATED DISORDERS
- Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
- (2012) Eugénie Lhommée et al. BRAIN
- Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease
- (2012) Domenico Bosco et al. CLINICAL NEUROPHARMACOLOGY
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
- (2012) Margarita Pondal et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
- (2012) Nicola J. Ray et al. NEUROBIOLOGY OF DISEASE
- Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease
- (2012) Anne-Louise Cunnington et al. PARKINSONISM & RELATED DISORDERS
- Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome
- (2012) Sarah J. Moum et al. PLoS One
- Cognitive-Behavioral Therapy for Pathological Gambling in Parkinsons Disease: A Pilot Controlled Study
- (2012) Susana Jiménez-Murcia et al. EUROPEAN ADDICTION RESEARCH
- Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
- (2011) Roseanne D. Dobkin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
- (2011) S. S. O'Sullivan et al. BRAIN
- Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats
- (2011) L Fattore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathological gambling and the treatment of psychosis with aripiprazole: case reports
- (2011) Neil Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation
- (2011) L. B. Zahodne et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine
- (2011) R.A. Walsh et al. MOVEMENT DISORDERS
- The selective mu-opioid receptor antagonist adl5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease
- (2011) James B. Koprich et al. MOVEMENT DISORDERS
- Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome
- (2011) S.R. Schreglmann et al. PARKINSONISM & RELATED DISORDERS
- Relationships between deep brain stimulation and impulse control disorders in Parkinson’s disease, with a literature review
- (2011) P. Shotbolt et al. PARKINSONISM & RELATED DISORDERS
- Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study
- (2010) Daniel Weintraub et al. ANNALS OF NEUROLOGY
- Pathological gambling in Parkinson disease is reduced by amantadine
- (2010) Astrid Thomas et al. ANNALS OF NEUROLOGY
- Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
- (2010) Christina A. Rabinak et al. ARCHIVES OF NEUROLOGY
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
- (2010) S. Thobois et al. BRAIN
- Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson’s disease
- (2010) Maria C. Rodriguez-Oroz et al. BRAIN
- Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects
- (2010) Kelly E. Lyons et al. CLINICAL NEUROPHARMACOLOGY
- The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Fatty Acid Amide Hydrolase (FAAH) Inhibition Reduces L-3,4-Dihydroxyphenylalanine-Induced Hyperactivity in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Non-Human Primate Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
- (2010) Adrian Williams et al. LANCET NEUROLOGY
- Clozapine for medication-related pathological gambling in Parkinson disease
- (2010) Alessandro Rotondo et al. MOVEMENT DISORDERS
- Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors
- (2010) Valerie Voon et al. NEURON
- Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
- (2009) T. D. L. Steeves et al. BRAIN
- Subthalamic deep brain stimulation and impulse control in Parkinson’s disease
- (2009) T. D. Hälbig et al. EUROPEAN JOURNAL OF NEUROLOGY
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial
- (2009) Frances M. Weaver JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease
- (2009) Shen-Yang Lim et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Olanzapine in the Treatment of Pathological Gambling
- (2009) Susan L. McElroy et al. JOURNAL OF CLINICAL PSYCHIATRY
- Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions
- (2009) Willi Gerschlager et al. MOVEMENT DISORDERS
- Impulsive and compulsive behaviors in Parkinson's disease
- (2009) Andrew H. Evans et al. MOVEMENT DISORDERS
- Rapid Resolution of Dopamine Dysregulation Syndrome (DDS) After Subthalamic DBS for Parkinson Disease (PD)
- (2008) David Knobel et al. Cognitive and Behavioral Neurology
- 1-Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques
- (2008) N. P. Visanji et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: Improvement on switching the target
- (2008) Delphine Raucher-Chéné et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats
- (2008) Andrea Bari et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now